{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:22:49Z","timestamp":1789168969369,"version":"build-2803163510"},"reference-count":306,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.neubiorev.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T05:28:06Z","timestamp":1639632486000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Beating pain with psychedelics: Matter over mind?"],"prefix":"10.1016","volume":"134","author":[{"given":"Igor","family":"Elman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pustilnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Borsook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0028-3908(95)00136-0","article-title":"Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators","volume":"35","author":"Abbott","year":"1996","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine\u2019s mechanism of action: a path to rapid-acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress. Anxiety"},{"issue":"10","key":"10.1016\/j.neubiorev.2021.12.005_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ijnp\/pyz041","article-title":"\"(R)-Ketamine induces a greater increase in prefrontal 5-HT release than (S)-Ketamine and ketamine metabolites via an AMPA receptor-independent mechanism","volume":"22","author":"Ago","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","article-title":"Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation","volume":"75","author":"Albrecht","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"17","key":"10.1016\/j.neubiorev.2021.12.005_bib0025","doi-asserted-by":"crossref","first-page":"e2038","DOI":"10.1212\/WNL.0000000000007371","article-title":"Imaging of neuroinflammation in migraine with aura: a [(11)C]PBR28 PET\/MRI study","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(93)90427-J","article-title":"Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors","volume":"249","author":"Alhaider","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neubiorev.2007.07.012","article-title":"The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations","volume":"32","author":"Allen","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.neuro.30.051606.094222","article-title":"Anatomical and physiological plasticity of dendritic spines","volume":"30","author":"Alvarez","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/dev.20563","article-title":"Plasticity of gray matter volume: the cellular and synaptic plasticity that underlies volumetric change","volume":"53","author":"Anderson","year":"2011","journal-title":"Dev. Psychobiol."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/pmt.11.53","article-title":"The brain in chronic pain: clinical implications","volume":"1","author":"Apkarian","year":"2011","journal-title":"Pain Manag."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0055","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1177\/0269881118798610","article-title":"The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women","volume":"32","author":"Argento","year":"2018","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0060","article-title":"Antioxidative and anti-inflammatory properties of Cannabidiol","volume":"9","author":"Atalay","year":"2019","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/11595200-000000000-00000","article-title":"Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review","volume":"26","author":"Azari","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(94)90149-X","article-title":"Response of chronic neuropathic pain syndromes to ketamine: a preliminary study","volume":"56","author":"Backonja","year":"1994","journal-title":"Pain"},{"issue":"20","key":"10.1016\/j.neubiorev.2021.12.005_bib0075","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"47","key":"10.1016\/j.neubiorev.2021.12.005_bib0080","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1523\/JNEUROSCI.3576-06.2006","article-title":"Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain","volume":"26","author":"Baliki","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","article-title":"Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116462","article-title":"Decreased directed functional connectivity in the psychedelic state","volume":"209","author":"Barnett","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/7854_2017_474","article-title":"Classic hallucinogens and mystical experiences: phenomenology and neural correlates","volume":"36","author":"Barrett","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0105","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0110","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0115","doi-asserted-by":"crossref","first-page":"niy008","DOI":"10.1093\/nc\/niy008","article-title":"Dimensions of consciousness and the psychedelic state","volume":"2018","author":"Bayne","year":"2018","journal-title":"Neurosci. Conscious."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nicl.2014.07.012","article-title":"Intrinsic brain networks normalize with treatment in pediatric complex regional pain syndrome","volume":"6","author":"Becerra","year":"2014","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0125","first-page":"2368","article-title":"CNS measures of pain responses pre- and post-anesthetic ketamine in a patient with complex regional pain syndrome","volume":"16","author":"Becerra","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"issue":"15","key":"10.1016\/j.neubiorev.2021.12.005_bib0135","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2174\/1389450121666200719011653","article-title":"Kratom dependence and treatment options: a comprehensive review of the literature","volume":"21","author":"Bin Abdullah","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bjorkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biopsych.2003.10.006","article-title":"Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease","volume":"55","author":"Blanpied","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/7854_2016_464","article-title":"Therapeutic applications of classic hallucinogens","volume":"36","author":"Bogenschutz","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neubiorev.2021.12.005_bib0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awr271","article-title":"Neurological diseases and pain","volume":"135","author":"Borsook","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/SLA.0b013e3182701a7b","article-title":"Surgically induced neuropathic pain: understanding the perioperative process","volume":"257","author":"Borsook","year":"2013","journal-title":"Ann. Surg."},{"issue":"249","key":"10.1016\/j.neubiorev.2021.12.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008320","article-title":"Lost but making progress--Where will new analgesic drugs come from?","volume":"6","author":"Borsook","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neubiorev.2016.05.033","article-title":"Reward deficiency and anti-reward in pain chronification","volume":"68","author":"Borsook","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0175","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1097\/j.pain.0000000000001401","article-title":"When pain gets stuck: the evolution of pain chronification and treatment resistance","volume":"159","author":"Borsook","year":"2018","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000542-199801000-00015","article-title":"Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations","volume":"88","author":"Bowdle","year":"1998","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1060028019892644","article-title":"Esketamine: a novel option for treatment-resistant depression","volume":"54","author":"Bozymski","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.119.263319","article-title":"Antinociceptive and immune effects of Delta-9-Tetrahydrocannabinol or cannabidiol in male versus female rats with persistent inflammatory pain","volume":"373","author":"Britch","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fnhum.2013.00657","article-title":"Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia","volume":"7","author":"Brogaard","year":"2013","journal-title":"Front. Hum. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1526-4610.1996.3604254.x","article-title":"Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine","volume":"36","author":"Buchwalder","year":"1996","journal-title":"Headache"},{"issue":"7842","key":"10.1016\/j.neubiorev.2021.12.005_bib0205","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41398-021-01230-z","article-title":"Low dose oral ketamine treatment in chronic suicidality: an open-label pilot study","volume":"11","author":"Can","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.neubiorev.2021.12.005_bib0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0220","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0225","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2016.01.053","article-title":"Different contexts, different pains, different experiences","volume":"338","author":"Carlino","year":"2016","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrrheum.2014.17","article-title":"Pain and the context","volume":"10","author":"Carlino","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/00034983.1992.11812673","article-title":"Current practices for the prevention and treatment of malaria in children and in pregnant women in the Brazzaville Region (Congo)","volume":"86","author":"Carme","year":"1992","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action","volume":"45","author":"Castellanos","year":"2020","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105788","article-title":"Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats","volume":"75","author":"Chang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nn0901-873","article-title":"Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice","volume":"4","author":"Chiamulera","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"218","key":"10.1016\/j.neubiorev.2021.12.005_bib0275","first-page":"1","article-title":"The effectiveness and risks of long-term opioid treatment of chronic pain","author":"Chou","year":"2014","journal-title":"Evid. Rep. Assess. (Full Rep)"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic plasticity: multiple forms, functions, and mechanisms","volume":"33","author":"Citri","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0285","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0361-9230(01)00527-5","article-title":"Glial cell abnormalities in major psychiatric disorders: the evidence and implications","volume":"55","author":"Cotter","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.649144","article-title":"Th17 cells in depression: are they crucial for the antidepressant effect of ketamine?","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0295","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.neubiorev.2021.12.005_bib0300","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1111\/bph.13919","article-title":"Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research","volume":"174","author":"Dauvermann","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02791072.2018.1487607","article-title":"A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification","volume":"50","author":"Davis","year":"2018","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J. Contextual Behav. Sci."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0315","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0320","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J. Med. Toxicol."},{"issue":"Suppl 12","key":"10.1016\/j.neubiorev.2021.12.005_bib0325","first-page":"16","article-title":"Common pathways of depression and pain","volume":"65","author":"Delgado","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0330","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","article-title":"Long-term cognitive and neurochemical effects of \u201cbath salt\u201d designer drugs methylone and mephedrone","volume":"103","author":"den Hollander","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0335","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","article-title":"Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0340","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review","volume":"47","author":"DiVito","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0345","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/bcpt.12637","article-title":"Antinociceptive and anti-inflammatory effects of ketamine and the relationship to its antidepressant action and GSK3 inhibition","volume":"119","author":"do Vale","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2019.1606472","article-title":"The past and future of psychedelic science: an introduction to this issue","volume":"51","author":"Doblin","year":"2019","journal-title":"J. Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0355","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/ALN.0000000000000243","article-title":"Psychedelics, glutamate, and neuroimaging studies","volume":"120","author":"dos Santos","year":"2014","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0360","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"15","key":"10.1016\/j.neubiorev.2021.12.005_bib0365","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jcpt.12238","article-title":"Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression","volume":"40","author":"Drewniany","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0375","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuron.2009.07.014","article-title":"Activation of the opioidergic descending pain control system underlies placebo analgesia","volume":"63","author":"Eippert","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archgenpsychiatry.2010.174","article-title":"The missing p in psychiatric training: why it is important to teach pain to psychiatrists","volume":"68","author":"Elman","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","article-title":"Pain and suicidality: insights from reward and addiction neuroscience","volume":"109","author":"Elman","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0395","first-page":"246","article-title":"Aberrant expression of immune-related MicroRNAs in pediatric patients with asthma","volume":"9","author":"Elnady","year":"2020","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00429-014-0717-9","article-title":"A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks","volume":"220","author":"Erbs","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0405","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1526-4610.1977.hed1703118.x","article-title":"Brief report: phantom limp pain: sub-hallucinogenic treatment with lysergic acid diethylamide (LSD-25)","volume":"17","author":"Fanciullacci","year":"1977","journal-title":"Headache"},{"issue":"Suppl 7","key":"10.1016\/j.neubiorev.2021.12.005_bib0410","first-page":"24","article-title":"Depression with physical symptoms: treating to remission","volume":"64","author":"Fava","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0415","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00000542-198204000-00011","article-title":"Opiate receptor mediation of ketamine analgesia","volume":"56","author":"Finck","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pnpbp.2016.02.012","article-title":"Drugs related to monoamine oxidase activity","volume":"69","author":"Fisar","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0425","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0430","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-2999(80)90079-5","article-title":"Failure of ketamine to interact with opiate receptors","volume":"61","author":"Fratta","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0435","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1527-3458.2004.tb00007.x","article-title":"The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA)","volume":"10","author":"Freudenmann","year":"2004","journal-title":"CNS Drug Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13041-020-00670-w","article-title":"Ketamine normalizes high-gamma power in the anterior cingulate cortex in a rat chronic pain model","volume":"13","author":"Friesner","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnint.2014.00035","article-title":"The anterior cingulate cortex and pain processing","volume":"8","author":"Fuchs","year":"2014","journal-title":"Front. Integr. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/rapm.2002.31205","article-title":"Chronic pain with beneficial response to electroconvulsive therapy and regional cerebral blood flow changes assessed by single photon emission computed tomography","volume":"27","author":"Fukui","year":"2002","journal-title":"Reg. Anesth. Pain Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0455","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/B:NEUR.0000011331.58835.fd","article-title":"5-HT2a receptors in rat sciatic nerves and Schwann cell cultures","volume":"32","author":"Gaietta","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0460","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fpsyt.2019.00955","article-title":"Persisting reductions in Cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: an online survey","volume":"10","author":"Garcia-Romeu","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0465","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0470","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neubiorev.2003.11.008","article-title":"Descending modulation of pain","volume":"27","author":"Gebhart","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0475","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-3057(02)00844-4","article-title":"Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors","volume":"73","author":"Gewirtz","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0480","first-page":"545","article-title":"Correction by physiotherapy of immune disorders in high-grade athletes","volume":"140","author":"Ghighineishvili","year":"1992","journal-title":"Clin. Ter."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0490","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jpain.2014.06.002","article-title":"The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States","volume":"15","author":"Groenewald","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fphar.2015.00046","article-title":"Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?","volume":"6","author":"Guiard","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0500","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0028-3908(84)90048-0","article-title":"Influence of naloxone on the effects of LSD in monkeys","volume":"23","author":"Hadorn","year":"1984","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0505","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cn300138m","article-title":"Animal models of serotonergic psychedelics","volume":"4","author":"Hanks","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0515","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0269881115598338","article-title":"Psilocybin, psychological distress, and suicidality","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0520","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0525","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/can.2020.0105","article-title":"The effects of cannabinoids on Pro- and anti-inflammatory cytokines: a systematic review of in vivo studies","volume":"6","author":"Henshaw","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0530","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/35104061","article-title":"Dendritic spines: structure, dynamics and regulation","volume":"2","author":"Hering","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"17","key":"10.1016\/j.neubiorev.2021.12.005_bib0535","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0540","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/clpt.2009.161","article-title":"Challenges in analgesic drug development","volume":"86","author":"Hewitt","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroimage.2016.12.032","article-title":"Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control","volume":"147","author":"Hoflich","year":"2017","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0550","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: a literature review","volume":"11","author":"Hojsted","year":"2007","journal-title":"Eur. J. Pain"},{"issue":"S6","key":"10.1016\/j.neubiorev.2021.12.005_bib0555","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.5694\/mja12.10589","article-title":"Depression and chronic pain","volume":"199","author":"Holmes","year":"2013","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0560","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0196-0644(96)70319-0","article-title":"Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma","volume":"27","author":"Howton","year":"1996","journal-title":"Ann. Emerg. Med."},{"issue":"1653","key":"10.1016\/j.neubiorev.2021.12.005_bib0565","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0522","article-title":"Perspective: network-guided pattern formation of neural dynamics","volume":"369","author":"Hutt","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0570","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/01.anes.0000435635.42332.ee","article-title":"Altered states: psychedelics and anesthetics","volume":"119","author":"Icaza","year":"2013","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0575","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/HRP.0000000000000198","article-title":"Pain and depression: a systematic review","volume":"26","author":"IsHak","year":"2018","journal-title":"Harv. Rev. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0580","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1592\/phco.27.11.1571","article-title":"Antidepressant agents for the treatment of chronic pain and depression","volume":"27","author":"Jann","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0585","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/jnp.2.1.44","article-title":"The role of excitatory amino acids in neuropsychiatric illness","volume":"2","author":"Javitt","year":"1990","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0590","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/neu.2019.15","article-title":"Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat","volume":"31","author":"Jefsen","year":"2019","journal-title":"Acta Neuropsychiatr."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0595","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pain.2013.02.011","article-title":"Multiple potential mechanisms for context effects on pain","volume":"154","author":"Jepma","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0600","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0605","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J. Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0610","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential therapeutic effects of psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2021.12.005_bib0615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2011.10.029","article-title":"Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers","volume":"123","author":"Johnson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0625","series-title":"Dextromethorphan Toxicity","author":"Journey","year":"2021"},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0630","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/mp.2017.109","article-title":"Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder","volume":"23","author":"Kadriu","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0635","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","article-title":"Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants","volume":"24","author":"Kadriu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0640","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/17425255.2019.1689958","article-title":"Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature","volume":"15","author":"Kamp","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0645","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/0004867413486842","article-title":"Ketamine as a new treatment for depression: a review of its efficacy and adverse effects","volume":"47","author":"Katalinic","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0650","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/BRS.0000000000000769","article-title":"The effect of a 5-HT2A receptor antagonist on pain-related behavior, endogenous 5-hydroxytryptamine production, and the expression 5-HT2A receptors in dorsal root ganglia in a rat lumbar disc herniation model","volume":"40","author":"Kato","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0655","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","article-title":"The impact of opioids on the endocrine system","volume":"25","author":"Katz","year":"2009","journal-title":"Clin. J. Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0660","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1213\/00000539-199909000-00024","article-title":"Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro","volume":"89","author":"Kawasaki","year":"1999","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0665","first-page":"198","article-title":"Alterations in the biochemical indices in Wistar rats exposed to an overdose of codeine and dextromethorphan","volume":"16","author":"Kayode","year":"2021","journal-title":"J Taibah Univ Med Sci"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0670","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/YCT.0b013e318282a6b1","article-title":"Electroconvulsive therapy attenuates dendritic arborization in the basolateral amygdala","volume":"29","author":"Khaleel","year":"2013","journal-title":"J. ECT"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0675","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112296","article-title":"Pharmacological regulation of neuropathic pain driven by inflammatory macrophages","volume":"18","author":"Kiguchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0680","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jocn.2012.07.009","article-title":"Ketamine for acute neuropathic pain in patients with spinal cord injury","volume":"20","author":"Kim","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0685","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"19","key":"10.1016\/j.neubiorev.2021.12.005_bib0690","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"issue":"46","key":"10.1016\/j.neubiorev.2021.12.005_bib0695","article-title":"Drifting assemblies for persistent memory: neuron transitions and unsupervised compensation","volume":"118","author":"Kossio","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0700","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/oxim.2.4.9380","article-title":"Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships","volume":"2","author":"Kovacic","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0705","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0710","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mcn.2012.03.005","article-title":"The dendritic tree and brain disorders","volume":"50","author":"Kulkarni","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0715","first-page":"22","article-title":"The effect of LSD on the phantom limb phenomenon","volume":"87","author":"Kuromaru","year":"1967","journal-title":"J."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0720","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320950567","article-title":"The therapeutic potential of microdosing psychedelics in depression","volume":"10","author":"Kuypers","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0725","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Microdosing psychedelics: motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"10","key":"10.1016\/j.neubiorev.2021.12.005_bib0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165461","article-title":"The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0740","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","article-title":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","volume":"159","author":"Lewis","year":"2017","journal-title":"Neuroimage"},{"issue":"15","key":"10.1016\/j.neubiorev.2021.12.005_bib0745","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1056\/NEJMe2102835","article-title":"Back to the future - the therapeutic potential of psychedelic drugs","volume":"384","author":"Lieberman","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0073-6","article-title":"Enhancement of 5-HT2A receptor function and blockade of Kv1.5 by MK801 and ketamine: implications for PCP derivative-induced disease models","volume":"50","author":"Lin","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0755","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11481-012-9422-8","article-title":"Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain","volume":"8","author":"Linnman","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0760","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.2235-16.2016","article-title":"TNF-alpha differentially regulates synaptic plasticity in the Hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury","volume":"37","author":"Liu","year":"2017","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.neubiorev.2021.12.005_bib0765","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/brain\/awu377","article-title":"Evidence for brain glial activation in chronic pain patients","volume":"138","author":"Loggia","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0770","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"Lopez-Gimenez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0775","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","article-title":"Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin","volume":"199","author":"Lord","year":"2019","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.neubiorev.2021.12.005_bib0780","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26102948","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117653","article-title":"LSD alters dynamic integration and segregation in the human brain","volume":"227","author":"Luppi","year":"2021","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib0790","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib0795","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/02791072.2012.736842","article-title":"Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner","volume":"44","author":"Lyvers","year":"2012","journal-title":"J. Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.neubiorev.2021.12.005_bib0800","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1523\/JNEUROSCI.2659-17.2018","article-title":"Ketamine alters lateral prefrontal oscillations in a rule-based working memory task","volume":"38","author":"Ma","year":"2018","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0805","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0960327107087802","article-title":"Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review","volume":"27","author":"Maciulaitis","year":"2008","journal-title":"Hum. Exp. Toxicol."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0810","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0815","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0820","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1213\/ANE.0000000000001787","article-title":"Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization","volume":"124","author":"Maher","year":"2017","journal-title":"Anesth. Analg."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0825","article-title":"A traditional scientific perspective on the integrated information theory of consciousness","volume":"23","author":"Mallatt","year":"2021","journal-title":"Entropy Basel (Basel)"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0830","doi-asserted-by":"crossref","DOI":"10.1021\/acs.inorgchem.1c02285","article-title":"NO coupling by nonclassical dinuclear dinitrosyliron complexes to form N2O dictated by hemilability","author":"Marks","year":"2021","journal-title":"Inorg. Chem."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0835","first-page":"851","article-title":"Beyond Cannabis: psychedelic decriminalization and social justice","volume":"23","author":"Marlan","year":"2019","journal-title":"Lewis and Clark Law Review"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0840","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cns.12072","article-title":"Ketamine: use in anesthesia","volume":"19","author":"Marland","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0845","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0850","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","article-title":"Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain","volume":"33","author":"Matsuda","year":"2019","journal-title":"J. Anesth."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0855","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0860","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","author":"McCulloch","year":"2021","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0865","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.expneurol.2011.11.016","article-title":"Dendritic spine plasticity as an underlying mechanism of neuropathic pain: commentary on Tan et al","volume":"233","author":"Melemedjian","year":"2012","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0870","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1073\/pnas.0809897106","article-title":"Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain","volume":"106","author":"Metz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0875","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0880","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fnhum.2014.00586","article-title":"Cues, context, and long-term memory: the role of the retrosplenial cortex in spatial cognition","volume":"8","author":"Miller","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0885","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818757098","article-title":"Retrosplenial cortex and its role in spatial cognition","volume":"2","author":"Mitchell","year":"2018","journal-title":"Brain Neurosci. Adv."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0890","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0895","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-3057(84)80090-8","article-title":"Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats","volume":"21","author":"Mokler","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0900","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bja\/aet126","article-title":"Challenges in design and interpretation of chronic pain trials","volume":"111","author":"Moore","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0905","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0910","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib0915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib0920","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1038\/s41598-019-49360-1","article-title":"Resting-state brain functional connectivity in patients with chronic pain who responded to subanesthetic-dose ketamine","volume":"9","author":"Motoyama","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0925","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/rapm-2020-101994","article-title":"Chronic pain and psychedelics: proceeding with caution","volume":"46","author":"Mukhdomi","year":"2021","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0930","article-title":"Acute effects of lysergic acid diethylamide (LSD) on resting brain function","volume":"149","author":"Muller","year":"2019","journal-title":"Swiss Med."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0935","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.pbr.2018.08.004","article-title":"Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: contributions of the resting brain","volume":"242","author":"Muller","year":"2018","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0940","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: a systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2021.12.005_bib0945","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib0950","first-page":"1675","article-title":"Involvement of peripheral 5-HT2A receptor activation in inflammatory pain","volume":"59","author":"Nakanishi","year":"2001","journal-title":"Nihon Rinsho"},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0955","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4155\/fmc.09.113","article-title":"Natural product scaffolds as leads to drugs","volume":"1","author":"Newman","year":"2009","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0960","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib0965","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib0970","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib0975","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.physiol.64.081501.160008","article-title":"Structure and function of dendritic spines","volume":"64","author":"Nimchinsky","year":"2002","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib0980","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuint.2005.06.002","article-title":"Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain","volume":"47","author":"Nitanda","year":"2005","journal-title":"Neurochem. Int."},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib0985","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/nn2001","article-title":"GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI","volume":"10","author":"Northoff","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib0990","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrn3530","article-title":"Effects of schedule I drug laws on neuroscience research and treatment innovation","volume":"14","author":"Nutt","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib0995","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1468-2982.1996.1607463.x","article-title":"Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene","volume":"16","author":"Nyholt","year":"1996","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib1000","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/glia.23994","article-title":"Implication of cerebral astrocytes in major depression: a review of fine neuroanatomical evidence in humans","volume":"69","author":"O\u2019Leary","year":"2021","journal-title":"Glia"},{"issue":"21","key":"10.1016\/j.neubiorev.2021.12.005_bib1005","doi-asserted-by":"crossref","first-page":"E1405","DOI":"10.1097\/BRS.0000000000003651","article-title":"Epidural corticosteroid injections for sciatica: an abridged cochrane systematic review and meta-analysis","volume":"45","author":"Oliveira","year":"2020","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-clinpsy-032816-045128","article-title":"Medical marijuana and marijuana legalization","volume":"13","author":"Pacula","year":"2017","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroimage.2019.06.053","article-title":"Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives","volume":"200","author":"Pallavicini","year":"2019","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e31827b1aa1","article-title":"Inflammation in complex regional pain syndrome: a systematic review and meta-analysis","volume":"80","author":"Parkitny","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib1045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"101","key":"10.1016\/j.neubiorev.2021.12.005_bib1050","doi-asserted-by":"crossref","first-page":"20140873","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc. Interface"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1055","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0133-15.2016","article-title":"Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex","volume":"3","author":"Phoumthipphavong","year":"2016","journal-title":"eNeuro"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib1060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0269881117691453","article-title":"The association of psychedelic use and opioid use disorders among illicit users in the United States","volume":"31","author":"Pisano","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2021.12.005_bib1065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0031-6997(25)06842-5","article-title":"100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug","volume":"47","author":"Popik","year":"1995","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110178","article-title":"A multimetric systematic review of fMRI findings in patients with MDD receiving ECT","volume":"108","author":"Porta-Casteras","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jcpt.12656","article-title":"The rapid-onset antidepressant effect of ketamine: more surprises?","volume":"43","author":"Raffa","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0959-4388(02)00313-6","article-title":"Brain mechanisms of pain affect and pain modulation","volume":"12","author":"Rainville","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269881120940937","article-title":"A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","volume":"35","author":"Ramaekers","year":"2021","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"1633","key":"10.1016\/j.neubiorev.2021.12.005_bib1100","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0157","article-title":"Synaptic competition in structural plasticity and cognitive function","volume":"369","author":"Ramiro-Cortes","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11916-002-0019-4","article-title":"Electroconvulsive therapy in the management of chronic pain","volume":"6","author":"Rasmussen","year":"2002","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 1","key":"10.1016\/j.neubiorev.2021.12.005_bib1115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1113\/jphysiol.2009.179382","article-title":"Activity-dependent synaptic plasticity of NMDA receptors","volume":"588","author":"Rebola","year":"2010","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib1120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1125","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.bjp.0702204","article-title":"Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine","volume":"125","author":"Ross","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2021.12.005_bib1130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/02791072.1979.10472098","article-title":"Entheogens","volume":"11","author":"Ruck","year":"1979","journal-title":"J. Psychedelic Drugs"},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib1135","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/0269881116679368","article-title":"Psychedelics in the treatment of unipolar mood disorders: a systematic review","volume":"30","author":"Rucker","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1152\/physrev.00012.2013","article-title":"Dendritic spines: the locus of structural and functional plasticity","volume":"94","author":"Sala","year":"2014","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib1150","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.celrep.2018.07.070","article-title":"Functional distinctions between spine and dendritic synapses made onto parvalbumin-positive interneurons in mouse cortex","volume":"24","author":"Sancho","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tins.2020.11.008","article-title":"A dendrite-focused framework for understanding the actions of ketamine and psychedelics","volume":"44","author":"Savalia","year":"2021","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858420914747","article-title":"Neuroimmune interactions in pain and stress: an interdisciplinary approach","volume":"27","author":"Sawicki","year":"2021","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1165","doi-asserted-by":"crossref","first-page":"46421","DOI":"10.1038\/srep46421","article-title":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","volume":"7","author":"Schartner","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib1170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/02791072.2015.1107664","article-title":"Indoleamine hallucinogens in cluster headache: results of the clusterbusters medication use survey","volume":"47","author":"Schindler","year":"2015","journal-title":"J. Psychoactive Drugs"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib1175","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib1180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/15563650701668625","article-title":"Dextromethorphan-induced serotonin syndrome","volume":"46","author":"Schwartz","year":"2008","journal-title":"Clin. Toxicol. Phila. (Phila)"},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246152","article-title":"Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET","volume":"16","author":"Seo","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neubiorev.2021.12.005_bib1190","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","article-title":"Response of cluster headache to psilocybin and LSD","volume":"66","author":"Sewell","year":"2006","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.neubiorev.2021.12.005_bib1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1200","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9724371","article-title":"The link between depression and chronic pain: neural mechanisms in the brain","volume":"2017","author":"Sheng","year":"2017","journal-title":"Neural Plast."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib1205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjp.0705998","article-title":"The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan","volume":"144","author":"Shin","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuint.2007.01.008","article-title":"Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats","volume":"50","author":"Shin","year":"2007","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib1215","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1526-4637.2010.00881.x","article-title":"Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain","volume":"11","author":"Shurman","year":"2010","journal-title":"Pain Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.21106\/ijma.284","article-title":"Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns","volume":"8","author":"Singh","year":"2019","journal-title":"Int. J. MCH AIDS"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage"},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib1230","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0028-3908(87)90084-0","article-title":"Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro","volume":"26","author":"Smith","year":"1987","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/YCT.0000000000000076","article-title":"Images in electroconvulsive therapy: ECS dose-dependently increases cell proliferation in the subgranular region of the rat hippocampus","volume":"30","author":"Smitha","year":"2014","journal-title":"J. ECT"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenbaek","year":"2021","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11064-019-02744-1","article-title":"Astroglial mechanisms of ketamine action include reduced mobility of Kir4.1-Carrying vesicles","volume":"45","author":"Stenovec","year":"2020","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of Ketamine\u2019s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1260","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"40","key":"10.1016\/j.neubiorev.2021.12.005_bib1265","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1523\/JNEUROSCI.1664-20.2020","article-title":"Sculpting dendritic spines during initiation and maintenance of neuropathic pain","volume":"40","author":"Stratton","year":"2020","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.0001-5172.2004.0312.x","article-title":"Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine","volume":"48","author":"Sun","year":"2004","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"10","key":"10.1016\/j.neubiorev.2021.12.005_bib1275","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14737175.2019.1640604","article-title":"Esketamine for treatment resistant depression","volume":"19","author":"Swainson","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1280","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphar.2018.00172","article-title":"Unifying theories of psychedelic drug effects","volume":"9","author":"Swanson","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib1290","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1002\/hbm.22562","article-title":"Enhanced repertoire of brain dynamical states during the psychedelic experience","volume":"35","author":"Tagliazucchi","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"8","key":"10.1016\/j.neubiorev.2021.12.005_bib1295","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-Induced Ego dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1300","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000542-199402000-00020","article-title":"Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice","volume":"80","author":"Takenaka","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1305","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/bs.pmbts.2014.12.001","article-title":"Dendritic spine dysgenesis in neuropathic pain","volume":"131","author":"Tan","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1310","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.expneurol.2011.08.026","article-title":"Spinal cord injury, dendritic spine remodeling, and spinal memory mechanisms","volume":"235","author":"Tan","year":"2012","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.expneurol.2011.08.028","article-title":"Rac1-regulated dendritic spine remodeling contributes to neuropathic pain after peripheral nerve injury","volume":"232","author":"Tan","year":"2011","journal-title":"Exp. Neurol."},{"issue":"20","key":"10.1016\/j.neubiorev.2021.12.005_bib1320","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1523\/JNEUROSCI.1017-12.2012","article-title":"Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain","volume":"32","author":"Tan","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1325","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1389296","article-title":"The role of descending pain modulation in chronic primary pain: potential application of drugs targeting serotonergic system","volume":"2019","author":"Tao","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1330","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.conb.2021.05.001","article-title":"Dendrite enlightenment","volume":"69","author":"Tavosanis","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.31887\/DCNS.2018.20.1\/fthibaut","article-title":"The mind-body Cartesian dualism and psychiatry","volume":"20","author":"Thibaut","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2020.10.001","article-title":"Psychedelics as a novel approach to treating autoimmune conditions","volume":"228","author":"Thompson","year":"2020","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1345","first-page":"211","article-title":"Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment","volume":"28","author":"Thrul","year":"2021","journal-title":"Drugs"},{"issue":"1668","key":"10.1016\/j.neubiorev.2021.12.005_bib1350","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0167","article-title":"Consciousness: here, there and everywhere?","volume":"370","author":"Tononi","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1355","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A classification of chronic pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","article-title":"Psilocybin--summary of knowledge and new perspectives","volume":"24","author":"Tyls","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/17.2.131","article-title":"Polyamine inhibitors","volume":"17","author":"Tyms","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"issue":"3\u20134","key":"10.1016\/j.neubiorev.2021.12.005_bib1370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000506812","article-title":"Neuropathic pain causes a decrease in the dendritic tree complexity of hippocampal CA3 pyramidal neurons","volume":"208","author":"Tyrtyshnaia","year":"2019","journal-title":"Cells Tissues Organs (Print)"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pain.2005.12.025","article-title":"Electroconvulsive therapy improves severe pain associated with fibromyalgia","volume":"121","author":"Usui","year":"2006","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1380","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0022034516638027","article-title":"The emotional brain as a predictor and amplifier of chronic pain","volume":"95","author":"Vachon-Presseau","year":"2016","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1385","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1038\/s41467-020-18628-w","article-title":"Author Correction: understanding the genetic determinants of the brain with MOSTest","volume":"11","author":"van der Meer","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1390","first-page":"234","article-title":"PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin","volume":"41","author":"van Dyck","year":"2000","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.neubiorev.2021.12.005_bib1395","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090331","article-title":"Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening Diseases-A systematic review and meta-analysis of clinical trials","volume":"8","author":"Vargas","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1400","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117049","article-title":"Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains","volume":"220","author":"Varley","year":"2020","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib1405","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1185\/03007991003689175","article-title":"Pharmacological treatment of chronic pain - the need for CHANGE","volume":"26","author":"Varrassi","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"issue":"7827","key":"10.1016\/j.neubiorev.2021.12.005_bib1410","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41586-020-2731-9","article-title":"Deep posteromedial cortical rhythm in dissociation","volume":"586","author":"Vesuna","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1415","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-Bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148737","article-title":"Positive allosteric modulator of GABA lowers BOLD responses in the cingulate cortex","volume":"11","author":"Walter","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neubiorev.2021.12.005_bib1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.03.002","article-title":"Functional divergence of Delta and mu opioid receptor organization in CNS pain circuits","volume":"98","author":"Wang","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2018.05.001","article-title":"Astrocytes activation contributes to the antidepressant-like effect of ketamine but not scopolamine","volume":"170","author":"Wang","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2018.08.015","article-title":"Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors","volume":"242","author":"Wang","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.neubiorev.2021.12.005_bib1440","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/jcmm.16426","article-title":"Neuroprotective effect of ketamine against TNF-alpha-induced necroptosis in hippocampal neurons","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2010\/382781","article-title":"A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain","volume":"15","author":"Watson","year":"2010","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1450","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fnins.2018.00661","article-title":"The changes of functional connectivity strength in electroconvulsive therapy for depression: a longitudinal study","volume":"12","author":"Wei","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1455","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neubiorev.2021.12.005_bib1460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/pmt-2017-0068","article-title":"Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?","volume":"8","author":"Whelan","year":"2018","journal-title":"Pain Manag."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/2054.2019.032","article-title":"Diversity, equity, and access in psychedelic medicine","volume":"4","author":"Williams","year":"2019","journal-title":"J. Psyched. Stud."},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1470","first-page":"CD007407","article-title":"Psychological therapies for the management of chronic pain (excluding headache) in adults","volume":"11","author":"Williams","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02690269","article-title":"Pavlov and the mind-body problem","volume":"32","author":"Windholz","year":"1997","journal-title":"Integr. Physiol. Behav. Sci."},{"issue":"3 Suppl","key":"10.1016\/j.neubiorev.2021.12.005_bib1480","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.neubiorev.2021.12.005_bib1485","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biopsych.2020.12.022","article-title":"Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms","volume":"89","author":"Wu","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1490","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2008.02.049","article-title":"Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats","volume":"1210","author":"Xie","year":"2008","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/j.neubiorev.2021.12.005_bib1495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133130","article-title":"Chronic pain: structural and functional changes in brain structures and associated negative affective states","volume":"20","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2021.12.005_bib1500","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/17512433.2020.1717947","article-title":"Emerging concepts on the use of ketamine for chronic pain","volume":"13","author":"Yang","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1505","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00213-020-05490-3","article-title":"Ketamine relieves depression-like behaviors induced by chronic postsurgical pain in rats through anti-inflammatory, anti-oxidant effects and regulating BDNF expression","volume":"237","author":"Yang","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1510","series-title":"Lessons Learned From Molecular Scaffold Analysis","first-page":"1742","author":"Ye","year":"2011"},{"key":"10.1016\/j.neubiorev.2021.12.005_bib1515","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fncir.2018.00061","article-title":"Ten-hour exposure to low-dose ketamine enhances corticostriatal cross-frequency coupling and hippocampal broad-band gamma oscillations","volume":"12","author":"Ye","year":"2018","journal-title":"Front. Neural Circuits"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.12.005_bib1520","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neuron.2011.07.024","article-title":"Dendritic spines and distributed circuits","volume":"71","author":"Yuste","year":"2011","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neubiorev.2021.12.005_bib1525","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2021.12.005_bib1530","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1152\/jn.01057.2015","article-title":"Dendritic spine remodeling following early and late Rac1 inhibition after spinal cord injury: evidence for a pain biomarker","volume":"115","author":"Zhao","year":"2016","journal-title":"J. Neurophysiol."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:07:46Z","timestamp":1758967666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763421005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":306,"alternative-id":["S0149763421005534"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.12.005","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beating pain with psychedelics: Matter over mind?","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}